Views & Analysis Brexit life sciences ‘beauty contest’ underway How the UK’s exit from the EU may influence pharma companies’ decisions to stay or go.
News Invest in NHS to boost life sciences, says pharma body Make NHS best place to research and launch drugs, says ABPI.
News UK will leave single market, pharma highlighted as key indus... May sets out plans to leave single market, and aim for EU free trade deal
News New NICE rules could deny drugs to rare disease patients Patients could be denied treatments, says BIA
News Despite Brexit, UK to join EU patent - biotech pleased The UK government has made the surprise to decision to join a new EU single patent and patent court - despite its plans for Brexit.
Views & Analysis UK business fears ‘Hard Brexit’, biotech sets out demands ‘Hard Brexit’ is worrying many businesses, including those in life sciences.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
